We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Tag: Propensity Score Matching
MedXY News
EnglishTag

Propensity Score Matching

Ask MedXY AI
type 2 diabetesclinical trialheart failureimmunotherapyobesitycardiovascular riskatrial fibrillationbiomarkerscritical careclinical trialsHypertensionartificial intelligenceCardiologyoncologypublic healthtype 1 diabetesdiabetesMortalityAlzheimer's diseasecardiovascular diseasebreast cancerepidemiology

Latest news

Tag

Impact of Combined Transcatheter Mitral and Tricuspid Edge-to-Edge Repair in Patients with Moderate Mitral Regurgitation and Severe Tricuspid Regurgitation
CardiologyMitral RegurgitationMultivalve Disease

Impact of Combined Transcatheter Mitral and Tricuspid Edge-to-Edge Repair in Patients with Moderate Mitral Regurgitation and Severe Tricuspid Regurgitation

By MedXY|Sep 11, 2026

This propensity-matched study shows that in patients undergoing tricuspid TEER for severe TR, untreated moderate MR is linked to worse survival, while combined mitral and tricuspid TEER improves mortality and functional outcomes, highlighti

Impact of Preoperative Serotonergic Antidepressants on Post-Rhinoplasty Outcomes: A Propensity Score-Matched Study
news术后并发症Rhinoplasty

Impact of Preoperative Serotonergic Antidepressants on Post-Rhinoplasty Outcomes: A Propensity Score-Matched Study

By MedXY|Aug 4, 2026

Preoperative use of serotonergic antidepressants is linked to increased short-term postoperative complications after rhinoplasty, including higher rates of bleeding, readmission, and opioid use, without affecting long-term revision rates.

Severe Hypertriglyceridemia: New Therapies and Evolving Understanding
Cardiologyplozasiransevere hypertriglyceridemia

Severe Hypertriglyceridemia: New Therapies and Evolving Understanding

By MedXY|Jul 25, 2026

Severe hypertriglyceridemia (TG >500 mg/dL) affects ~1 in 88 adults and carries risks of pancreatitis and cardiovascular disease. Novel therapies targeting apoC-III, notably plozasiran siRNA, demonstrate dramatic TG reductions and pancreatitis risk mitigation. Pediatric management remains guideline-limited. Standardization of definitions is needed.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story